Cramer Rosenthal McGlynn »

SPDR S&P Biotech shares owned by Cramer Rosenthal McGlynn

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Cramer Rosenthal McGlynn from 13F filings

Historical chart of Cramer Rosenthal McGlynn investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Cramer Rosenthal McGlynn consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Cramer Rosenthal McGlynn

Quarter filed Position value Share count Share price at filing
2024-06-30 $5.2M 57k 92.71
2024-03-31 $4.7M 50k 94.89
2023-12-31 $2.9M 32k 89.29

More positions owned by Cramer Rosenthal McGlynn

First American Financial (FAF)
Skyline Corporation (SKY)
Acva (ACVA)
Ciena Corporation (CIEN)
Concentra Group Holdings Par (CON)
Sun Communities (SUI)
Bio-techne Corporation (TECH)
Elanco Animal Health (ELAN)
Terreno Realty Corporation (TRNO)
Arcosa (ACA)
Ashland (ASH)
Regal-beloit Corporation (RRX)
Atmos Energy Corporation (ATO)
Ptc (PTC)
Victorias Secret And (VSCO)

View all positions for Cramer Rosenthal McGlynn

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Jpmorgan Chase & Co
Healthcare Of Ontario Pension Plan Trust Fund
Bank of America Corporation
Citigroup
Jane Street
Millennium Management
Citadel Advisors
Susquehanna International
PEAK6 Investments
UBS Group
NWI Management
Bnp Paribas Arbitrage, Snc
Parallax Volatility Advisers
Wells Fargo & Company

View all funds holding SPDR S&P Biotech